ANTI- IL27R ANTIBODIES AND METHODS OF USE THEREOF

    公开(公告)号:US20240052047A1

    公开(公告)日:2024-02-15

    申请号:US18363152

    申请日:2023-08-01

    Applicant: Pfizer Inc.

    CPC classification number: C07K16/2866 C07K16/2803 A61K2039/505

    Abstract: The present invention relates to antibodies that specifically bind to one or both of IL27RA and gp130. The present invention further relates to bispecific antibodies that specifically bind to IL27RA and gp130. The present invention also pertains to related molecules, e.g. nucleic acids which encode such antibodies or bispecific antibodies, compositions, and related methods, e.g., methods for producing and purifying such antibodies and bispecific antibodies, and their use in diagnostics and therapeutics

Patent Agency Ranking